Struggling DNA testing firm 23andMe to be bought for $256m
Lily Jamali Reporting fromSan Francisco, CA Reuters The DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m). It comes two months after the company filed for bankruptcy protection in the US. 23andMe said Regeneron had committed to comply with its privacy policies as part … Read more